James G. Bender, VP, Product Development & Mfg at ImmunoCellular Therapeutics, Ltd. (IMUC), sold 20,579 shares at $2.88 ($60K) on 2013-08-28, disclosed to the SEC on 2013-08-30.
Open-market sale of $60k IMUC by VP, Product Development & Mfg. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.84 | 5,000 | $14K | 23.8% |
| 2 | $2.85 | 3,303 | $9K | 15.8% |
| 3 | $2.88 | 5,000 | $14K | 24.1% |
| 4 | $2.98 | 6,376 | $19K | 31.8% |
| 5 | $3.00 | 900 | $3K | 4.5% |
| Total | $2.90 avg | 20,579 |
| $60K |
| 100% |
| Filing → |